Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Cancer Biol. 2004 Jun;14(3):181-5.

Chemokines in neoplastic progression.

Author information

  • Neurocrine Biosciences, 10555 Science Center Drive, San Diego, CA 92121, USA. azlotnik@neurocrine.com

Abstract

Chemokines and their receptors have emerged as attractive targets regulating the migration of tumor cells in vivo, a process known as cancer metastasis. The control of metastasis is critical to the control of cancer progression. Two chemokine receptors and their ligands stand out as likely targets for therapeutics: CCR7/CCL21 for lymph node metastases, and CXCR4/CXCL12 for lung, liver, bone marrow, and brain metastases. The most widely expressed chemokine receptor among cancers is likely to be CXCR4.

PMID:
15246053
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk